Skip to main content
Contact Us
Subscribe
E-Edition
78°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Archives
Best of 2025
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about FDA
Recent news which mentions FDA
< Previous
1
2
...
26
27
28
29
30
31
32
33
Next >
EXCLUSIVE: The Psychedelics Debate Is 'Raging' As Filament Debuts Ayahuasca Pill
December 16, 2022
Tickers
CMPS
FLHLF
Tags
Clinical Data
Small Cap
Management
From
Benzinga
FDA OKs Ketamine For Treating Organ Transplant Injuries With 'Orphan Drug' Status
December 15, 2022
Tickers
PHRRF
Tags
News
Penny Stocks
Legal
From
Benzinga
EXCLUSIVE: Ayahuasca Pill Is Officially Here, Filament CEO Discusses Future Plans
December 15, 2022
Tickers
AGNPF
ATAI
FLHLF
Tags
Benjamin Lightburn
Market News
Cannabis
From
Benzinga
FDA Slaps Clinical Hold On Miromatrix's For Bioengineered Liver Platform
December 15, 2022
Tickers
MIRO
Tags
News
Briefs
Trading Ideas
From
Benzinga
FDA Extends Review Period For AstraZeneca-Merck Partnered Cancer Drug, Lynparza
December 15, 2022
Tickers
AZN
AZNCF
MRK
Tags
General
Large Cap
AZNCF
From
Benzinga
Cytokinetics AdComm Outcome Might Be Blessing In Disguise, This Analyst Said
December 14, 2022
Tickers
CYTK
Tags
why it's moving
Trading Ideas
News
From
Benzinga
FDA Adcomm Gives Thumbs Down To Cytokinetics' Heart Failure Candidate
December 14, 2022
Tickers
CYTK
Tags
Trading Ideas
Briefs
News
From
Benzinga
Cannabis Insider: Expert Predicts FDA Will 'Legitimize' CBD By End Of This Year
December 13, 2022
Tickers
CBD
Tags
CBD
Sheri Orlowitz
Elliot Lane
From
Benzinga
Another Competitor For Amgen As FDA Approves Mirati Therapeutics' KRAS Inhibitor For Lung Cancer Setting
December 13, 2022
Tickers
MRTX
Tags
premarket trading
Biotech
Benzinga
From
Benzinga
Biotricity Files FDA 510(k) For Expanded Use Of Its Biotres Cardiac Monitoring Device
December 12, 2022
Tickers
BTCY
Tags
Trading Ideas
News
Briefs
From
Benzinga
Psychedelics And Treatment-Resistant Depression: COMPASS Pathways Replies To Comments
December 09, 2022
Tickers
CMPS
Tags
Markets
Compass Pathways
Legal
From
Benzinga
AVROBIO Announces Clinical Data For Gaucher Disease Gene Therapy; Says 'Following positive feedback from FDA and MHRA, registrational, global Phase 2/3 clinical trial for GD3 planned for second half 2
December 07, 2022
Tickers
AVRO
Tags
FDA
Market News
News
From
Benzinga
Mirati Plays Catch-Up With Amgen, Gilead's 2nd Try With AIDS Drug, Cytokinetics' Adcom Test And More: Key Nov FDA Decisions For Biotech Investors
December 02, 2022
Tickers
AMGN
CHRS
CYTK
IBB
Tags
SPPI
PRVB
Trading Ideas
From
Benzinga
Regeneron's Evkeeza Under FDA Priority Review For Younger Kids With Inherited Form Of High Cholesterol
November 30, 2022
Tickers
REGN
Tags
General
Large Cap
REGN
From
Benzinga
Aeglea Nosedives After Clinical Update On Investigational Candidate For Rare Metabolism Disease
November 30, 2022
Tickers
AGLE
Tags
Benzinga
Biotech
Health Care
From
Benzinga
After FDA Rejection, Spectrum Shelves Development On Poziotinib
November 25, 2022
Tickers
SPPI
Tags
Health Care
Benzinga
Biotech
From
Benzinga
< Previous
1
2
...
26
27
28
29
30
31
32
33
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.